Read More Pharma Industry News How Polyrizon’s NASARIX branding strengthens PL-14’s positioning in non-drug allergy prevention Find out how Polyrizon’s NASARIX branding move positions its PL-14 allergy blocker for regulatory progress and future commercialization. bySoujanya RaviJanuary 11, 2026